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Background
Chronic hand eczema (CHE) represents an inflammatory
skin disease with a high prevalence ranging from 7-12% in
Western industrialized countries. It was only starting from
2008 that the first, and until now the only, systemic treat-
ment option, i.e. oral alitretinoin was approved in several
countries for severe CHE unresponsive to potent topical
corticosteroids. However, as the precise mechanism of
actions (MOA) of alitretinoin in CHE are so far unknown,
we undertook following investigations in order to shed
some light on potential underlying immunomodulatory
mechanisms.
Materials and methods
To investigate the mode of action of alitretinoin we stimu-
lated human primary keratinocytes as well as leukocyte
subsets and performed quantitative real-time PCR ana-
lyses, FACS-analyses, cell-proliferation assays as well as
mixed leukocyte reactions (MLR).
Results
Alitretinoin acts on keratinocytes as well as dendritic cells.
Keratinocytes show a significant reduction of chemokine
expression after stimulation with alitretinoin whereas on
dendritic cells alitretinoin inhibits the upregulation of the
maturation marker CD83 as well as the co-stimulatory
molecules CD80 and CD86. Consequently, alitretinoin-
treated dendritic cells show significantly impaired T cell
activating properties. Further analyses demonstrated that
the immunomodulatory effect of alitretinoin results in a
marked suppression of allogenic proliferation of leukocytes
in MLR.
Conclusions
Taken together, these results suggest that alitretinoin
modulates innate as well as adaptive immune responses
by suppression of chemokine-induced leukocyte recruit-
ment and inhibition of dendritic cell-mediated T cell
activation.
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